An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell Carcinoma

Sponsors and Collaborators

GlaxoSmithKline

 
Contact

US GSK Clinical Trials Call Center


Continue Reading

877-379-3718
 
Investigators

GSK Clinical Trials

GlaxoSmithKline
  

ClinicalTrials.gov Identifier

NCT00992121